Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer.
about
Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phase I study of the combinati ...... ic non small cell lung cancer.
@en
Phase I study of the combinati ...... ic non small cell lung cancer.
@nl
type
label
Phase I study of the combinati ...... ic non small cell lung cancer.
@en
Phase I study of the combinati ...... ic non small cell lung cancer.
@nl
prefLabel
Phase I study of the combinati ...... ic non small cell lung cancer.
@en
Phase I study of the combinati ...... ic non small cell lung cancer.
@nl
P2860
P1476
Phase I study of the combinati ...... ic non small cell lung cancer.
@en
P2093
Afshin Dowlati
Neelesh Sharma
P2860
P2888
P304
P356
10.1007/S10637-017-0515-3
P577
2017-10-02T00:00:00Z